With regards to helping patients as well as the business
With regards to helping patients as well as the business model, the viral vector is interesting because in theory it does not just have to be applied to HIV patients. If leronlimab is proven effective, would it make sense to offer this gene therapy to have the body produce leronlimab on its own as a super vitamin, anti-aging therapy for many people in the population. If so, how do you price it. Who would qualify. There are only a handful of approved gene therapies in the past 5 years most priced at about 1 million a treatment.
What may be uniqie about leronlimab versus other drugs like keytruda is the potential broad systemic benefit towards multiple diseases along with a pristine safety profile which possibly gives the rationale towards a broadly administered gene therapy. For example, if HIV patients are the only ones who qualify, and they then start outliving everyone in the general population including the delta32 homozygous mutation patients (the theory is that leronlimab immunomodulates just right which may make it more therapeutic than the delta32 homozygous mutation), will others demand it as well. What will be the impact towards staggard patents for several conditions that might expire 20 years apart. What will this do towards the overal cost of health care and human longevity?
I suppose if the above becomes true, it would be a good propblem to have for patients and shareholders.
6
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A New Chapter for PROYA Bet you didn't see this one coming: a leading Chinese beauty brand, PROYA, is throwing its hat into the North American skincare ring, rolling out its science-backed skincare line nationwide at Ulta Beauty. The same brand that's been big news across Asia is now setting its sights on the U.S. with a stunning array of products that don't just promise...
Continue Reading
A Windfall for Career Readiness Here’s a nugget of hope wrapped in a crisp announcement: Genesys Works, the not-for-profit that’s been busy nuancing the work-play balance for high school kids, is rolling with a $4 million boost from Ballmer Group. This move isn’t just pennies from heaven; it's a strategic play designed to gird young folks for the evolving demands of...
Continue Reading
Cracking the Idaho Massage School Code Idaho folks diving into massage therapy education need a playbook—timing, training, and all the bumps along the way. This journey's not just book reading and back rubs; it’s a structured affair with rigid hours and some bureaucratic hurdling. Thank goodness for Kylee Evans, who’s spilling the beans on what goes down in Idaho...
Continue Reading
Seems Lululemon just tripped on its yoga mat. When a company like Lululemon Athletica, Inc (NASDAQ:LULU) sees a 17.38% slide in stock, every savvy investor knows there's more beneath the surface. Squarely in the crosshairs of a securities fraud class action, the brand synonymous with upscale athleisure faces harsh scrutiny. And the deadline's ticking—even the suits know...
Continue Reading
Revving Up: VinFast's Bold Battery Bet Some days it feels like every automaker is just looking for ways to tether drivers to mileage limitations, but VinFast is ripping up the rulebook. Their promise of a 10-year, unlimited-mileage battery warranty has got tongues wagging, and for good reason. Under typical policies, drivers with long commutes or adventurous spirits face...
Continue Reading
Discovering Cangxi's Development Playbook Picture this: a band of African scholars deep-diving into China's rural heartland, Cangxi, in Sichuan province, trying to unlock the secrets behind its impressive cultural and industrial achievements. On November 4, a delegation from the Horn of Africa arrived as part of a training workshop organized by China's Ministry of Foreign...
Continue Reading
CytoSorbents' Financial Turnaround Imagine the smell of fresh opportunity wafting through CytoSorbents’ (NASDAQ:CTSO) corridors this quarter. The company just nudged into positive territory with its operating cash flow, which, let’s be honest, is like finding a nugget of gold amid last year’s rubble of losses. With $43,000 of positive operating cash flow in a world...
Continue Reading
Times are changing, and the digital landscape keeps morphing—who can keep up? That's exactly what's on the agenda as McKenzie Finkhousen and Alton Baird lead HelloNation into the 2026 PHCC of NC Annual Meeting. This ain't just another LinkedIn meet-up—this is a proper gathering of minds in plumbing, heating, and cooling biz right at Harrah's Cherokee Casino Resort....
Continue Reading
The Wine Industry's Digital Splash Ah, the wonderful world of wine—a place where culture, taste, and that sweet bouquet of a well-aged vintage collide. It’s no secret that the wine industry is a cash cow, raking in more than $323 billion annually in the U.S. alone. Digital Information Resources (DIR), a savvy player in tech and media circles, decided this bubbling...
Continue Reading
Understanding the Importance of Year-Round Tax Planning Every small business owner dreads the tax season—like a thunderstorm on a picnic day. But here's a nugget from Paul Kersten, an Accounting and Tax whiz in Shawano, Wisconsin: don't wait until April to sort your taxes. By then, it's all receipts and regrets. Instead, consider tax planning as a year-long vigil. Why?...
Continue Reading
Top 5 Most Recently Viewed Articles
Pagaya Technologies Strengthens Financial Position with Auto ABS Pagaya Technologies LTD. (NASDAQ: PGY), a leading global technology firm, has achieved an important milestone in its journey by successfully closing a substantial $300 million auto asset-backed securitization (ABS) transaction. This notable achievement, labeled RPM 2025-1, reflects Pagaya's innovative...
Continue Reading
Acknowledging Legal Excellence in Dallas Hilgers Graben’s Dallas office continues to make significant strides in the legal community, gaining noteworthy recognition. The managing partner, Grant Schmidt, along with senior counsel Andrew Bean, have both secured a spot on D Magazine’s distinguished list of the 'Best Lawyers Under 40.' This annual accolade celebrates...
Continue Reading
Earning Recognition in the Entrepreneurial Landscape Walker Healthforce, led by the inspiring Tifiany Walker, has made a significant mark in the entrepreneurial scene, recently being honored as a finalist for the Entrepreneur Of The Year 2025 Award. This initiative, celebrating its 40th year, has been the pinnacle of acknowledging business leaders who are not just...
Continue Reading
Positive Phase 1 Results for TML-6 MerryLife Biomedical Inc., an innovative clinical-stage biotechnology company focused on neurodegenerative diseases, recently shared encouraging news about their investigational oral therapy, TML-6, targeting Alzheimer's disease. The recent Phase 1 trial indicated that TML-6 was well-tolerated and exhibited a favorable safety profile,...
Continue Reading
Impressive Quarterly Performance Clariant recently reported exceptional financial performance for the fourth quarter of 2024, showcasing growth across all its business segments. The company achieved sales of CHF 1.091 billion, reflecting a 5% increase in local currency compared to the previous year. This rise in sales can be attributed to a significant volume increase,...
Continue Reading